Top Clinical Trials companies in India by Net Cash Used For Investing Activities

This ranking features the top 2 Clinical Trials companies in India ranked by Net Cash Used For Investing Activities, totaling a Net Cash Used For Investing Activities of USD 2.20 M, for February 01, 2025.

India

Clinical Trials
Net Cash Used For Investing Activities
#
Name
Net Cash Used For Investing Activities
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
SUVEN.NS

Suven Life Sciences Limited

1

SUVEN.NS
USD 11.32 M
March 31, 2024 USD 1.48 10.54%

India
2
VIMTALABS.NS

Vimta Labs Limited

2

VIMTALABS.NS
USD -9.12 M
March 31, 2024 USD 9.86 2.71%

India
Frequently Asked Questions
  • Which Clinical Trials company in India has the highest Net Cash Used For Investing Activities ?

    The Clinical Trials company in India with the highest Net Cash Used For Investing Activities is Suven Life Sciences Limited (NSE: SUVEN.NS) at USD 11.32 M.

  • Which Clinical Trials company in India has the lowest Net Cash Used For Investing Activities ?

    The Clinical Trials company in India with the lowest Net Cash Used For Investing Activities is Vimta Labs Limited (NSE: VIMTALABS.NS) at USD -9.12 M.

  • What are the top 10 Clinical Trials companies in India by Net Cash Used For Investing Activities ?

    The top 10 Clinical Trials companies in India by Net Cash Used For Investing Activities are Suven Life Sciences Limited and Vimta Labs Limited.

  • What are the bottom 10 Clinical Trials companies in India by Net Cash Used For Investing Activities ?

    The bottom 10 Clinical Trials companies in India by Net Cash Used For Investing Activities are Vimta Labs Limited and Suven Life Sciences Limited.

SV Wall Street